Overview

Determinants in Antidepressant Outcomes

Status:
Withdrawn
Trial end date:
2005-09-01
Target enrollment:
Participant gender:
Summary
This study is designed to understand if a biological measurement, of how platelets respond to serotonin (a chemical in the blood sometimes referred to as SERT), can provide information that will determine an "ideal dose," one specifically tailored for each individual's chemistry. The biological measurement will be obtained by testing a blood sample. There will be approximately 120 control subjects expected for enrollment.
Phase:
N/A
Details
Lead Sponsor:
US Department of Veterans Affairs
VA Office of Research and Development
Treatments:
Antidepressive Agents
Fluoxetine